NASDAQ · Biotechnology

Iovance Biotherapeutics Inc (IOVA)

$9.36 +1.08%

Add alert

70 Overbought Daily RSI (14) · 15 Sep 2026

Moving averages

SMA 200$4.05+131.11%

Company profile

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

SectorHealthcare

IndustryBiotechnology

Market cap$3.90B

P/E ratioNone

EPS$-0.73

Beta0.833

Dividend yield0.00%

52-week high$9.36

52-week low$1.76

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 44 VRTX Vertex Pharmaceuticals Inc RSI 44 CRSP CRISPR Therapeutics AG RSI 41 MRNA Moderna Inc RSI 60 VKTX Viking Therapeutics Inc RSI 34 SRPT Sarepta Therapeutics Inc RSI 54 EDIT Editas Medicine Inc RSI 40 NVAX Novavax Inc RSI 51 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 46 RXRX Recursion Pharmaceuticals Inc - Class A RSI 47

Free forever

RSI alerts for IOVA

Get an email the moment Iovance Biotherapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 2:58 AM EDT